Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management
Call your clinician promptly if you have: Persistent vomiting, inability to keep fluids down, or signs of dehydration Severe or persistent abdominal pain (ask about pancreatitis and gallbladder warnings) Plans for surgery or procedures requiring anesthesia (labels include anesthesia-related precautions) Medication interactions: Zepbounds label notes it delays gastric emptying and may affect absorption of oral medications
In our practice (SN), we routinely use gastric ultrasound (GUS) to guide clinical decision-making, supported by a dedicated team of credentialed POCUS experts available in the operating room
Injection Anxiety or Administration Difficulties 3.4
US$ 28.35
US$ 25.07
US$ 23.75
US$ 26.84
US$ 21.64
US$ 24.05
US$ 22.24
US$ 21.47
US$ 26.58
US$ 21.54
